You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Direct-to-consumer sales for obesity drugs are about to boom. JPMorgan sees Eli Lilly as big winner ⊕⊕

found 2026 › Feb › 25 (Wed) @ 16:28 UTC

a story from CNBC ⚠️ › Top News

⊕⊕ Positive overall

0.00 negativity

0.73 neutrality

0.27 positivity